NOVACTA
Biological pathways
Harnessing Biological Systems
Novacta Biosystems is a biotechnology company with a proprietary technology platform that harnesses the specificity and efficiency of biological systems, including biosynthetic pathway engineering, biotransformations and metabolite factories, in drug discovery and commercial applications in the chemicals industry.
Novacta Biosystems delivers innovative products and services into the healthcare, food, cosmetic and chemical industries. Through the utilisation of leading edge technology and many years of experience in the pharmaceutical and biotechnology industry, Novacta has been able to meet the commercial requirements of several clients and partners while continuing to develop internal products.
Access to Novacta’s skills and insights is possible through collaborations and/or licence arrangements
Teachers are selected among experts of Lantibiotics in full Screen Novacta’s pharmaceutical research and development focuses on biologically active compounds produced by microorganisms, also known as ‘natural products’. Novacta has identified an exciting class of compounds, known as lantibiotics, as a target for development. The lantibiotics are highly modified peptides, combining the beneficial biological interactions and versatility of peptides with desirable pharmaceutical properties such as stability in the systemic circulation. These compounds have good potential as therapeutic agents, possessing a broad range of biological activities.
Fighting resistance
Lantibiotics have shown promising activity against bacteria resistant to commonly used antibacterials, including methicillin resistant Staphylococcus aureus (MRSA). These compounds have not previously progressed to clinical trials, however, because their complex structure has made it difficult to optimise their activity through conventional routes. Novacta’s innovative technology platform is designed to address this issue, enabling the structure of these complex molecules to be customised to order during their biosynthesis.
New Therapeutic Areas
As a result of the wide variety of structures that can be generated by Novacta’s technology platform, we are currrently in the process of developing several novel drug candidates within therapeutic areas including anti-virals, oncology and respiratory diseases.working effectively in their fields of excellence.
At Novacta, our proprietary technology platform enables the generation of a diverse range of molecular structures, unlocking new possibilities for drug discovery and development. As a result, we are actively advancing several novel drug candidates across multiple high-impact therapeutic areas, including anti-virals, oncology, and respiratory diseases.
Advancing the Fight Against Viral Infections
Our research into anti-viral therapeutics focuses on developing next-generation treatments that address both emerging and resistant viral pathogens. By leveraging our platform’s ability to design highly targeted molecules, we aim to deliver breakthrough therapies with enhanced efficacy and safety. Our approach holds promise in tackling a wide range of viral infections, including those with urgent unmet medical needs.
Innovating in Oncology to Improve Patient Outcomes
Cancer remains one of the most complex and challenging areas of medicine, and Novacta is committed to revolutionizing oncology treatment through precision drug development. Our platform allows us to create novel compounds that can selectively target cancer cells, modulate key signaling pathways, and overcome resistance mechanisms. By focusing on innovative mechanisms of action, we aim to provide more effective and personalized treatment options for patients across different types of cancer.
Transforming the Landscape of Respiratory Disease Treatments
Respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary infections, pose significant healthcare burdens worldwide. Novacta is harnessing its technology to develop new respiratory therapeutics that offer improved treatment efficacy, better patient compliance, and fewer side effects. By addressing inflammation, immune responses, and infection control, we are working toward novel solutions that could significantly enhance patient quality of life.
Commitment to Excellence and Future Exploration
With a strong foundation in scientific expertise and innovation, Novacta continues to expand its research and development efforts into additional therapeutic frontiers. Our ability to generate highly specific and effective drug candidates places us at the forefront of novel drug discovery. As we push the boundaries of what is possible, we remain dedicated to delivering transformative medicines that address pressing medical challenges and improve global health outcomes.
By working at the intersection of technology, chemistry, and biology, Novacta is poised to make a profound impact on the future of medicine. Stay tuned as we continue to unveil groundbreaking advancements in the field of therapeutics.